Fig. 3From: The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr miceLevels of serum complements (C3, C4) and lupus autoimmune marker (A-ds-DNA) in MRL/lpr mice. *P < 0.05 compared between CRIg/FH treated mice (black dot) and each control group (vertical bar). NS = normal saline; Pred = prednisone; The CRIg/FH treatment at indicated dose was administrated twice a weekBack to article page